Literature DB >> 7930751

Measles: state of the art and future directions.

B G Gellin1, S L Katz.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7930751     DOI： 10.1093/infdis/170.supplement_1.s3

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.

Authors:  P Aaby; B Samb; F Simondon; A M Seck; K Knudsen; H Whittle
Journal:  BMJ       Date:  1995-08-19

2.  Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection.

Authors:  J Mongkolsapaya; A Jaye; M F Callan; A F Magnusen; A J McMichael; H C Whittle
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domains.

Authors:  A Hirano; Z Yang; Y Katayama; J Korte-Sarfaty; T C Wong
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection.

Authors:  S Yant; A Hirano; T C Wong
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.

Authors:  A P Durbin; M H Skiadopoulos; J M McAuliffe; J M Riggs; S R Surman; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Clinical isolates of measles virus use CD46 as a cellular receptor.

Authors:  M Manchester; D S Eto; A Valsamakis; P B Liton; R Fernandez-Muñoz; P A Rota; W J Bellini; D N Forthal; M B Oldstone
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.

Authors:  A Jaye; A F Magnusen; A D Sadiq; T Corrah; H C Whittle
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

8.  Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.

Authors:  Yosuke Amagai; Tomoko Fujiyuki; Misako Yoneda; Koichiro Shoji; Yoichi Furukawa; Hiroki Sato; Chieko Kai
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.